June 5, 2014 |
Marye H. Godinez, 68, of Bryn Mawr, a medical researcher and mother of six, died of lung cancer Thursday, May 29, at her home. Dr. Godinez, an early multitasker, pursued a passion for medical research on the biochemical nature of the lung while raising her children in Bryn Mawr. Son Paul said Dr. Godinez was a master at finding the balance between work and family. At one point, she told her children it was time for them to take on some of the responsibilities of running a home.
May 21, 2014 |
Until four years ago, medical professionals across Major League Baseball were not speaking the same language. The league finally installed an injury surveillance system, and in 2011 Michael Ciccotti was appointed to lead an elbow study group under baseball's medical advisory committee. Ciccotti, the Phillies' head team physician and director of sports medicine at the Rothman Institute, initiated research on the ulnar collateral ligament, now the most-discussed tissue in baseball.
April 20, 2014 |
Sometimes, it takes one angry accountant to get things done. Doctors have been aware of anosmia - the inability to smell - "as far as I know, forever," says Gary Beauchamp, director of the Monell Chemical Senses Center in West Philadelphia. But they've never been able to do much about it. Monell scientists are working to change that. In February, they began a campaign to find a treatment for anosmia. And the campaign was spurred, in large part, by a letter Beauchamp received from one fed-up, anosmic accountant about a year ago. "He had lost his sense of smell.
March 24, 2014 |
When Denise Savarese, 60, of Sicklerville learned that she had a progressive form of multiple sclerosis in 1992, she feared breaking the news to her mother. Yet before she could, her mother pointed to herself and said, "I heard you have this. " She could not bear to say out loud that her daughter shared the MS that had severely limited her own life. But given major advances in MS care over the last 20 years, Savarese's path would differ greatly from her mother's. In 1993, Savarese was put on the first injectable drug for MS, betaseron, a form of interferon that can prevent flare-ups.
March 20, 2014 |
GLASSBORO Rowan University announced Tuesday that it had entered an agreement with Lockheed Martin to have the company collaborate with the university's students and faculty on research and development of radar technology. The move builds on a project begun last fall and, Rowan administrators said, is a new model for universities working with industry. The school has made high-profile pledges to expand, especially its research enterprise, with the engineering school seen as a core part of that mission.
March 20, 2014
HARRISBURG The Pennsylvania Coalition Against Rape (PCAR) on Wednesday awarded its annual Vision of Hope grant to Chiara Sabina to assess the current knowledge and attitudes of Pennsylvanians regarding child sexual abuse. Sabina, an assistant professor of social sciences at Penn State Harrisburg, is also an independent researcher of interpersonal violence, particularly sexual assault, intimate partner violence, and teen dating violence. PCAR grants up to $50,000 each year from its Vision of Hope Fund to support prevention projects in Pennsylvania and across the country to help teach adults how to create safer environments for children.
March 14, 2014 |
HARRISBURG Auditor General Eugene DePasquale announced Wednesday that he was undertaking an audit of the state health department's handling of nearly $800 million in research funding provided by the national tobacco settlement. "These funds are intended to fuel health-care research that could help people live longer, healthier, and more rewarding lives," DePasquale said. "We have to make sure these research programs are meeting expectations so that nothing jeopardizes their vital mission or erodes public confidence.
March 13, 2014 |
GLASSBORO Months after it became the second state-recognized public research university in New Jersey, Rowan University on Tuesday announced a new effort to connect faculty and student research initiatives with the dollars needed to kick-start them. The Rowan University Foundation, a fund-raising branch of the university, has allocated $5 million to the new program, called the Rowan Venture Fund. University officials said that the new fund was unique in the region and that it would help research ideas get started at "their earliest stages," potentially breeding job growth and economic activity.
March 9, 2014 |
With surgery and chemotherapy, Roberta Bash, 67, of Downingtown beat advanced-stage ovarian cancer in 2010. Then, it came back. "Cancer can go dormant, and I didn't know that," she said. The second time, Bash wanted to explore all her options - including an experimental treatment at Penn Medicine that manipulates a patient's tumor cells to trigger an immune response. So, during her surgery last March, instead of allowing her tumor to be tossed out or donated for research, she saved it. The company StoreMyTumor, which markets itself as a concierge service for tumors, negotiated the tissue's harvest, processing, and cryopreservation.
March 7, 2014 |
University of Pennsylvania researchers have snipped out a single gene in patients' immune cells to make them partly resistant to infection with HIV, the virus that causes AIDS. The study, in this week's New England Journal of Medicine, bolsters hope for controlling HIV without daily antiviral drugs - a so-called functional cure. But even more important, as the first paper to report the modification of an exact spot in human DNA, it marks the arrival of the age of gene editing.